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Abstract The extracellular calcium-binding (EC) module of 
human testican (115 residues) was obtained in native form by 
recombinant production in mammalian cell culture and thus 
shown to represent an independently folding domain. This module 
showed a large loss in a-helix upon calcium depletion. 
Apparently only one of the two EF hands binds calcium, with a 
moderate affinity (K¿ = 68 μΜ) about 100-fold lower than in the 
homologous BM-40 protein. No clear evidence was obtained for 
collagen binding, indicating that EC modules found in different 
proteins may not share similar functions. 
© 1997 Federation of European Biochemical Societies. 
Key words: Calcium binding; EF hand; Extracellular matrix; 
Recombinant protein 
1. Introduction 
A large number of extracellular proteins are known to bind 
calcium with moderate to high affinity and calcium-binding 
consensus sequences exist within at least five different protein 
modules [1]. One of these consists of a pair of EF hands, as 
initially shown for the extracellular matrix protein BM-40/os-
teonectin/SPARC [2,3] and is referred to as the extracellular 
calcium-binding (EC) module [4,5]. In BM-40 it exists in close 
association with a follistatin-like (FS) module and the struc-
ture of both has recently been elucidated by X-ray crystallog-
raphy [5,6]. The combination of an FS and EC module seems 
to be common to several other proteins, as shown by recent 
sequence analyses. They include the proteoglycan testican 
[7,8], the quail retina protein QR1 [9], the brain protein SCI 
[10], the endothelial protein hevin [11] and the protein TSC-
36/FRP [12,13]. The structural and functional relationships of 
these proteins to BM-40 are still unknown and only a few 
studies exist on their tissue expression [8,14-16]. 
Many functions have been identified for BM-40, including 
regulation of cell shape and gene expression, high affinity 
binding of calcium and interactions with several extracellular 
ligands [3,4]. The EC module of human BM-40 was shown to 
contain two calcium-binding sites and their occupation stabil-
izes part of the oc-helical conformation [4,5]. The same module 
also promotes calcium-dependent binding to several collagen 
types [4,17] and calcium-independent binding to platelet-de-
rived growth factor (W. Göhring, T. Sasaki, C.-H. Heldin, R. 
Timpl, in preparation). Enhanced collagen binding was ob-
served after the cleavage of a single peptide bond in the EC 
module by matrix metalloproteinases [17], suggesting that sim-
ilar activation mechanisms may exist in tissues. The EC mod-
ule of Caenorhabditis elegans BM-40 was also shown to bind 
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mammalian collagens as avidly as human BM-40, indicating 
the conservation of a particular function [18]. 
In the present study we examined the EC module of human 
testican [7,8], which shows several sequence deletions when 
compared to BM-40. By using a modified episomal expression 
vector we could obtain this EC module in apparently native 
form. Some but not all of its properties were similar to those 
of BM-40 and the data can now be interpreted from the se-
quence differences and the available X-ray structure. 
2. Materials and methods 
2.1. Construction of an episomal expression vector with puromycin 
resistance 
The eukaryotic episomal expression vector pCEP-Sh of 9.27 kbp 
[19] was used to produce a modified vector pCEP-Pu (9.51 kbp) by 
replacing the phleomycin (Shble) by the puromycin (pac) [20] resist-
ance gene in order to allow a more convenient puromycin selection in 
mammalian cells. A 8.79 kbp fragment was obtained by digestion of 
pCEP-Sh with Rsrll and partial cleavage with £s/EII, which elimi-
nated the EM7 promoter and Shble. Vector pSV2pac, containing the 
pac gene [21], was used for the generation of terminal cloning sites 
and the elimination of internal Rsrll and BstEll sites by silent muta-
genesis using polymerase chain reaction (PCR) with Vent polymerase 
(New England Biolabs) according to the supplier's instruction. The 
following synthetic primers were used (mutated nucleotides in small 
letters): Purla 5'-TGGAGGGTGACCGCCACGACCGGTGCCG; 
Pur2b 5'-GCCGTCGGACCGGGGTCGTGCGCTCCTT; Purlb 5'-
TCGATGTGGCGGTCgGGGTCGACG; Pur2a 5'-GACCGCCAC-
ATCGAaCGcGTCACCGAG. The primers Purla/Purlb and Pur2a/ 
Pur2b matching the restriction sites Rsrll and ÄsfEII and mutations 
were used to produce two overlapping fragments of pac, which were 
purified by agarose gel electrophoresis, annealed and used for five 
PCR cycles. After addition of Purla/Pur2b, 30 more PCR cycles 
were carried out. The product was digested with RsrlllBstEll, puri-
fied, inserted into the restricted pCEP-Sh vector and transformed into 
E. coli XL-1 blue (Stratagene). The correct insertion and sequence 
were verified by cycle sequencing on a 373A DNA sequencer (Applied 
Biosystems). 
2.2. Construction of a testican expression vector and cell transfection 
Vector pCEP-Pu (see above) was further modified by inserting some 
of the 5'UTR and the signal peptide sequence region of human BM-
40 to yield pCEP-Pu/BM40s. This region was released as a 105 bp 
fragment from expression vector pRc/Ac [22] by HindllllNhel restric-
tion and ligated to the same restriction sites downstream of the CMV 
promoter of pCEP-Pu. A cDNA fragment spanning the EC module of 
human testican, residues 197-311 [7], was generated by PCR from 2 μΐ 
of a human fetal brain 5' stretch XDR2 library (Clontech) using the 5' 
primer 5'-CCTAGCTAGCCTGCACAGACAAGGAGTTG and the 
3' primer 5'-CAGTTAGCGGCCGCTAGAGACCTCCAGGCTTC-
TGG. The primers introduced new restriction sites (Nhel, Notl) and 
a stop codon [22]. The Nhel/Notl restricted PCR product was purified 
and inserted between the same restriction sites of pCEP-Pu/BM40s in 
order to obtain the final expression vector pCEP-Pu/EC-test. The 
correct insertion and sequence was verified by cycle sequencing. Hu-
man embryonic kidney cells which constitutively express the EBNA-1 
protein from Epstein-Barr virus (293 EBNA, Invitrogen) were used 
for transfection [23]. The initial selection of transfected cells was ac-
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complished in the presence of 1-5 μί*/piι1 puromycin, which was then 
reduced to 0.5 μ&ΊηΙ during the phase of collecting serum-free culture 
medium. 
2.3. Protein purification 
Conditioned serum-free medium (1 1) was dialyzed against 0.05 M 
Tris-HCl, pH 8.6, containing protease inhibitors [24] and passed at 
4°C over a DEAE cellulose column (2.5x20 cm) equilibrated in the 
same buffer. The column was eluted with a linear 0-0.5 M NaCl 
gradient (500 ml) and the recombinant protein eluted as a major 
peak at 0.03-0.12 M NaCl. It was further purified on a Superóse 12 
column (HR16/50, Pharmacia) equilibrated in 0.2 M ammonium ace-
tate pH 6.8. Recombinant EC modules of human [4] and C. elegans 
[18] BM-40 have been previously described. 
2.4. Circular dichroism andfluorimetry 
Circular dichroism (CD) spectra were recorded with a Jasco 715 
CD spectropolarimeter at 25°C in thermostatted quartz cells of optical 
pathlength 1 mm. The molar ellipticity [0] (expressed in deg cm2 
dmol-1) was calculated on the basis of a mean residue molecular 
mass of 110 Da. The a-helical content was estimated according to 
[25]. Fluorescence was measured on a LS50B spectrophotometer (Per-
kin Elmer, Überlingen, Germany) in 10 mm pathlength rectangular 
cells. For measurement of intrinsic fluorescence, the excitation wave-
length was set at 280 nm and fluorescence was measured at the emis-
sion maximum of 346 nm. Protein concentrations were calculated 
from absorption at 279 nm using ε = 23000 Μ- 1 cm-1. Calcium titra-
tions and data evaluation were performed as previously described [4]. 
2.5. Miscellaneous methods 
Amino acid and hexosamine compositions were determined on a 
LC 3000 analyzer (Biotronik) after hydrolysis (16 h, 110°C) with 6 M 
or 3 M HC1, respectively. SDS gel electrophoresis followed standard 
protocols. Edman degradation of electroblotted protein bands was 
performed on a Procise sequencer (Applied Biosystems) following 
the manufacturer's instructions. Solid phase and surface plasmon res-
onance binding assays with collagens were those used previously 
[4,17]. Production of rabbit antisera and radioimmunoassays followed 
established protocols [26]. Human tissue extracts were from Clontech. 
An extract of human placenta (50 g) was prepared by homogenization 
in 200 ml 0.05 M Tris-HCl pH 8.6, 0.5 M NaCl (24 h, 4°C). 
3. Results 
We prepared a modified, cost-efficient episomal expression 
vector based on puromycin resistance and used it for the 
recombinant expression of the EC module of human testican 
5000 
Fig. 1. SDS gel electrophoresis of recombinant EC modules from 
human testican and BM-40. Lanes were loaded with 2 μg of testican 
EC (1, 2) and BM-40 EC (3, 4) and examined under reducing (1, 3) 
and non-reducing (2, 4) conditions. The calibration with reduced 
protein standards is shown in the left margin. 
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Fig. 2. Circular dichroism spectra of testican EC module. Far UV 
spectra were recorded at a protein concentration of 0.18 mg/ml in 
the presence of 2 mM Ca2+ (solid line) and 3 mM EDTA (dashed 
line) in 5 mM Tris-HCl, pH 7.4. 
in mammalian cells. The module (residues 197-311) was con-
nected to the BM-40 signal peptide region [22], which directed 
the product to the culture medium and added an N-terminal 
APL to the authentic testican sequence. The recombinant EC 
module could be purified from the culture medium in good 
yield (1-3 mg/1) by two Chromatographie steps. In SDS gel 
electrophoresis, the purified fragment showed a major 14 kDa 
band which shifted to a slower mobility after reduction, in-
dicating the opening of internal disulfide bonds (Fig. 1). This 
agreed with a calculated molecular mass of 13.4 kDa for the 
recombinant testican EC module, while the same module of 
BM-40 is about 30 residues larger [5] and has a slower electro-
phoretic mobility (see Fig. 1). Edman degradation of the 14 
kDa testican band demonstrated a single N-terminal sequence 
APLAXTDKELRN, as expected. Omission of protease inhib-
itors from the initial purification steps caused partial degra-
dation of the 14 kDa band to a 5 kDa band with a major N-
terminal sequence DTSILP, indicating cleavage at position 
237/238 of the EC module. 
The amino acid composition of the EC module of testican 
was identical to that predicted from the sequence within the 
limits of analytical error (data not shown). Hexosamine anal-
ysis of the EC module demonstrated substitution by 1.4 ±0.4 
residues glucosamine and 1.910.3 residues galactosamine. 
This indicated the presence of one or two O-linked oligosac-
charides, in agreement with a molecular mass of 14.4 kDa 
determined by ESI mass spectrometry, suggesting a 1 kDa 
mass contribution by post-translational modifications. The 
recombinant testican EC module showed a distinct conforma-
tion, as demonstrated by CD spectroscopy in the far UV 
region (Fig. 2). The spectra were characteristic of a protein 
with a high a-helical content, with minima at 208 and 222 nm. 
In the presence of calcium, the oc-helix was estimated to rep-
resent 32% of the entire structure. 
A rabbit antiserum was raised against the testican EC mod-
ule and had a moderate ELISA titer (1:200) for the recombi-
nant product but showed no reaction with human BM-40 
even at a dilution of 1:10. Immunoblotting of several human 
tissue extracts (skin, heart, skeletal muscle) demonstrated a 
distinct band of about 45-50 kDa, which corresponded in 
E. Kohfeldt et al.lFEBS Letters 414 (1997) 557-561 559 
size to that expected for the testican core protein [7] (data not 
shown). For more quantitative analyses, we also established a 
sensitive radioimmunoinhibition assay where 50% inhibition 
could be achieved with 0.2 nM testican EC module (Fig. 3). 
No inhibition was observed with 1000-fold higher concentra-
tions of BM-40 or its EC module obtained from human or C. 
elegans. Likewise a radioimmunoinhibition assay specific for 
human BM-40 [23] could not be inhibited by the testican EC 
module (not shown) demonstrating lack of cross-reactivity. 
Culture medium from human epithelial HBL-100 cells and a 
NaCl extract of human placenta could inhibit the assay for 
the testican EC module (Fig. 3) demonstrating that they con-
tain testican at a low concentration (0.1-0.7 nM). Their in-
hibition profiles were parallel to that of the testican EC mod-
ule which indicated that they share identical immunological 
epitopes [26]. 
As predicted [4,5], the EC module of testican showed a 
distinct affinity for calcium. Depletion of calcium by EDTA 
caused a 41% increase in molar ellipticity at 222 nm (Fig. 2), 
similar to that observed for the EC module of BM-40 [4]. This 
increase was used to quantitatively monitor calcium binding. 
A simple one binding site model could be fitted to the binding 
curve, with an equilibrium dissociation constant of K¿ = 68 
μΜ (Fig. 4). A second signal used to monitor calcium binding 
of the BM-40 EC module was intrinsic fluorescence, which 
showed an increase of about 100% upon calcium removal 
[4]. Upon excitation at 280 nm, the testican EC module 
showed an emission maximum at 346 nm. The intensity of 
intrinsic fluorescence, however, was only slightly (7%) altered 
upon addition of excess calcium (data not shown). In order to 
exclude interference by a putative high affinity calcium bind-
ing site 4 mM EDTA was added to the protein but did not 
change fluorescence intensity. 
A further calcium-dependent property of the BM-40 EC 
module is binding to various immobilized collagens in solid 
phase and surface plasmon resonance assays [4,17,18]. Similar 
solid phase tests with the testican EC module showed a weak 
but calcium-independent binding to collagen IV but no bind-
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Fig. 3. Radioimmunoinhibition assay with an antiserum against tes-
tican EC module. The assay consisted of 126I-labelled testican EC 
module (1 ng) and a fixed dilution of a rabbit antisera against this 
module. Inhibitors used were human testican EC module (·), hu-
man BM-40 (o), C. elegans BM-40 EC module ( Δ ) , a human pla-
centa extract ( A ) and conditioned serum-free medium of human 
HBL-100 cells (■). 
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Fig. 4. Calcium binding of testican EC domain as monitored by cir-
cular dichroism. Ellipticity at 222 nm was recorded as a function of 
the total Ca2+ concentration and transformed to degree of satura-
tion Y. Best fit curve with a fit parameter Kd = 68 μΜ is shown as 
a continuous line. 
ing to collagen I, laminin and fibronectin. Furthermore, no 
binding could be detected to either of the two collagens by 
surface plasmon resonance assay (data not shown). 
4. Discussion 
The calcium-binding EC module represents a novel struc-
ture found in extracellular proteins [2,4] and was shown to 
consist of EF hands 1 and 2 as well as several more a-helical 
and loop segments which together form a compact globular 
structure [5]. Extensive characterization of this module for 
human, mouse and C. elegans BM-40 [4,5,17,18,27,28] dem-
onstrated that calcium binds to two sites, including both EF 
hands, and that a change in a-helical conformation and bind-
ing affinity for collagens are both calcium-dependent. Other 
binding ligands may include oligomeric vitronectin [29] and 
platelet-derived growth factor (unpublished). The structure of 
an FS module adjacent to an EC module of BM-40 has also 
been elucidated and this structure may possess affinity for 
heparin [6]. A family of at least four more proteins [7-16] 
exists, all of which share the combination of EC and FS 
modules but differ in the length of their N-terminal domains. 
Two members, testican and TSC-36/FRP, differ in addition by 
C-terminal extensions beyond the EC module and larger dele-
tions within their EC module, the latter being shown for tes-
tican in Fig. 5. 
The functional relationships of these proteins are still un-
clear and have been approached here by the recombinant 
production of the testican EC module. This demonstrated, 
as for BM-40 [4], that this module represents an autono-
mously folding unit within the protein. Its folding into a di-
sulfide-bonded, native structure was also ascertained by CD 
spectroscopy, electrophoresis, calcium binding and immuno-
logical assays which demonstrated cross-reaction with testican 
in tissues and cell cultures. The recombinant module also 
underwent some post-translational modifications and, like 
the EC module of BM-40, showed a considerable change in 
a-helical conformation upon depletion of calcium. 
Previous studies have shown that calcium binding to BM-40 
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Fig. 5. Sequence comparison of the EC modules of human BM-40 and testican. Identical or conserved amino acids are shown on a black or 
shaded background, respectively. Triangles indicate two additional Cys residues in testican that may form a disulfide bridge. The star denotes 
the position of Phe291 in testican that corresponds to the Ca2+-coordinating residue Asp259 of BM-40. Lines above BM-40 indicate the positions 
of a-helices (oeA-aG) as determined by X-ray crystallography [5]. 
involves a non-canonical EF hand 1 where the insertion of a 
single additional residue in the 12 residue consensus sequence 
[30] is compensated for by a cw-peptide bond, providing a 
novel ligation site [5]. This insertion does not exist in testican 
(Fig. 5), but nevertheless our data indicate only one calcium 
binding site for its EC module with a moderate affinity of 
K¿ = 68 μΜ. An affinity about 100-fold higher was previously 
determined for the BM-40 EC module [4]. We prefer to ex-
plain this difference by the substitution of a ligating Asp res-
idue by Phe291 in the +Y position of EF hand 2 (Fig. 5), 
which could prevent calcium binding to this site. Similar 
Ala substitutions at the same site in troponin C [31] and 
aequorin [32] were previously shown to perturb calcium bind-
ing. This possibility is underscored by recent observations (E. 
Busch, P. Mauer, unpublished) of a cooperative effect in the 
calcium binding to EF hands 1 and 2 in BM-40, as revealed 
by single mutations in individual ligation sites which reduced 
affinities from KA < 1 μΜ to 50-200 μΜ. Proof of our inter-
pretation will still depend on additional equilibrium dialysis 
experiments and appropriate mutations in the testican EC 
module, however. Fluctuations in tissue calcium concentra-
tions may exist and could bring the concentration close to 
the K¿ value of testican binding, and this is of particular 
interest in neuronal tissues [1,33,34] due to the recently docu-
mented testican expression in the brain [8]. 
A further difference with BM-40 is the failure of intrinsic 
fluorescence to demonstrate calcium binding to the testican 
EC module, even though the K¿ value was not too low and 
the three Trp residues probably responsible are conserved in 
BM-40 testican (Fig. 5). We assume that an additional disul-
fide bridge, Cys245-Cys302 (Fig. 5), which could form in testi-
can based on the X-ray structure of BM-40 [5] and which 
would covalently link EF hands 1 and 2, as well as several 
deletions may prevent appropriate interactions. The same fail-
ure of intrinsic fluorescence to demonstrate calcium binding 
was observed with C. elegans BM-40, but in addition there 
was no conformational change on calcium depletion [18]. C. 
elegans BM-40 also contains several deletions and an addi-
tional disulfide bridge in its EC module, but these are different 
from that observed for testican [18,35]. Fewer sequence differ-
ences exist for the BM-40 related proteins QR1 [9] and SCI/ 
hevin [10,11], which could indicate that their properties more 
closely resemble those of BM-40. 
BM-40 has also been shown to be a versatile binding pro-
tein for collagens [3,4,17,18,27], though with moderate affinity 
(K¿ = 1-2 μΜ), through calcium-dependent interactions with 
the EC module. Binding activity could be increased by pro-
teolysis in helix aC, indicating a controlling mechanism 
[17,27]. No convincing evidence could so far be obtained for 
a similar function for the testican EC module which lacks a 
counterpart of helix aC (Fig. 5) but can apparently be modi-
fied at a different position by endogenous proteolysis. This has 
still to be further examined but suggests that the family of 
proteins sharing the FS and EC modules have possibly 
evolved different functions. 
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